Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Collapsing focal segmental glomerulosclerosis (FSGS) is a distinct clinicopathologic entity seen most commonly in young African American patients who present with renal insufficiency and nephrotic syndrome. The only epidemiologic factor previously linked to collapsing FSGS is HIV infection. Here clinicopathologic findings are reported for a distinctive population of seven patients, who were older, Caucasian, and HIV negative and developed collapsing FSGS during active treatment of malignancy (multiple myeloma in six patients and metastatic breast carcinoma in one). Although oncologic treatment regimens included vincristine for four patients, doxorubicin for five patients, cisplatin for two patients, and total-body irradiation for one patient, the only agent common to all patients was pamidronate (Aredia). All patients had normal renal function before the administration of pamidronate. Patients began therapy with pamidronate at or below the recommended dose of 90 mg, intravenously, monthly, which was increased to 180 mg monthly in two patients and 360 mg monthly in three patients. Patients received pamidronate for 15 to 48 mo before presentation with renal insufficiency (mean serum creatinine, 3.6 mg/dl) and full nephrotic syndrome (mean 24-h urinary protein excretion, 12.4 g/d). Pamidronate, which is a member of the class of bisphosphonates, is widely used in the treatment of hypercalcemia of malignancy and osteolytic metastases. At the recommended dose of 90 mg, intravenously, monthly, renal toxicity is infrequent; however, higher doses have produced nephrotoxicity in animal models. The temporal association between pamidronate therapy and the development of renal insufficiency, the use of escalating doses that exceed recommended levels, and the distinctive pattern of glomerular and tubular injury strongly suggest a mechanism of drug-associated podocyte and tubular toxicity. These data provide the first association of collapsing FSGS with toxicity to a therapeutic agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Cellular and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Monkkonen, J., & Frith, J. C. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2961::aid-cncr12>3.0.co;2-l · Cited by 977
Kunzmann, V., Bauer, E., Feurle, J., Tony, F. W., & Wilhelm, M. (2000) · Blood · doi:10.1182/blood.v96.2.384 · Cited by 669
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2038 · Cited by 631
Integrin-mediated Signals Regulated by Members of the Rho Family of GTPases
Clark, E. A., King, W. G., Brugge, J. S., Symons, M., & Hynes, R. O. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.573 · Cited by 603
BARISONI, L., KRIZ, W., MUNDEL, P., & D'AGATI, V. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10151 · Cited by 557
Self-citationHaas, M., Meehan, S. M., Karrison, T. G., & Spargo, B. H. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90485-6 · Cited by 451
Adverse Effects of Bisphosphonates: A Comparative Review
Adami, S., & Zamberlan, N. (1996) · Drug Safety · doi:10.2165/00002018-199614030-00003 · Cited by 377
Lithium Nephrotoxicity: A Progressive Combined Glomerular and Tubulointerstitial Nephropathy
MARKOWITZ, G. S., RADHAKRISHNAN, J., KAMBHAM, N., VALERI, A. M., HINES, W. H., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181439 · Cited by 352
Self-citationRenal Epithelium Is a Previously Unrecognized Site of HIV-1 Infection
BRUGGEMAN, L. A., ROSS, M. D., TANJI, N., CARA, A., DIKMAN, S., GORDON, R. E., BURNS, G. C., D'AGATI, V. D., WINSTON, J. A., KLOTMAN, M. E., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11112079 · Cited by 324
Self-citationTHE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS
Gibbs, J. B., & Oliff, A. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.143 · Cited by 324
The many masks of focal segmental glomerulosclerosis
D'Agati, V. (1994) · Kidney International · doi:10.1038/ki.1994.388 · Cited by 295
Self-citationDetwiler, R. K., Falk, R. J., Hogan, S. L., & Jennette, J. C. (1994) · Kidney International · doi:10.1038/ki.1994.185 · Cited by 290
Amin, D., Cornell, S., Gustafson, S., Needle, S., Ullrich, J., Bilder, G., & Perrone, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41388-4 · Cited by 281
Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study
Valeri, A., Barisoni, L., Appel, G. B., Seigle, R., & D'Agati, V. (1996) · Kidney International · doi:10.1038/ki.1996.493 · Cited by 261
Self-citationThe racial prevalence of glomerular lesions in nephrotic adults
Korbet, S. M., Genchi, R. M., Borok, R. Z., & Schwartz, M. M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90098-0 · Cited by 217
Neuroimaging Findings in Twins Discordant for Alzheimer’s Disease
Pedersen, N. L., Miller, B. L., Loebach Wetherell, J., Vallø, J., Toga, A. W., Knutson, N., Mehringer, C. M., Small, G. W., & Gatz, M. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017097 · Cited by 180
Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study
Laurinavicius, A., Hurwitz, S., & Rennke, H. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00769.x · Cited by 176
HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy
Barisoni, L., Bruggeman, L. A., Mundel, P., D'agati, V. D., & Klotman, P. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00152.x · Cited by 175
Self-citationZhang, D., Udagawa, N., Nakamura, I., Murakami, H., Saito, S., Yamasaki, K., Shibasaki, Y., Morii, N., Narumiya, S., Takahashi, N., et al. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2285 · Cited by 169
Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy
Zojer, N., Keck, A. V., & Pecherstorfer, M. (1999) · Drug Safety · doi:10.2165/00002018-199921050-00004 · Cited by 167
Diamond, J. R., & Karnovsky, M. J. (1986) · PubMed · Cited by 124
Rogers, M. J., Ji, X., Russell, R. G. G., Blackburn, G. M., Williamson, M. P., Bayless, A. V., Ebetino, F. H., & Watts, D. J. (1994) · Biochemical Journal · doi:10.1042/bj3030303 · Cited by 102
Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat Models
Green, J. R., Seltenmeyer, Y., Jaeggi, K. A., & Widler, L. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb01964.x · Cited by 89
広井, 恵., Kameda, T., Hiura, K., Mano, H., Miyazawa, K., Nakamaru, Y., Watanabe-Mano, M., Okuda, N., Shimada, J., Yamamoto, Y., et al. (1999) · Calcified Tissue International · doi:10.1007/s002239900606 · Cited by 74
Cited by
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Focal Segmental Glomerulosclerosis
D'Agati, V. D., Kaskel, F. J., & Falk, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1106556 · Cited by 825
Self-citationPathologic classification of focal segmental glomerulosclerosis: a working proposal
D'Agati, V. D., Fogo, A. B., Bruijn, J. A., & Jennette, J. C. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.024 · Cited by 776
Self-citationFocal Segmental Glomerulosclerosis
Rosenberg, A. Z., & Kopp, J. B. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05960616 · Cited by 562
Metadata
- Authors
- MARKOWITZ, G. S., APPEL, G. B., FINE, P. L., FENVES, A. Z., LOON, N. R., JAGANNATH, S., KUHN, J. A., DRATCH, A. D., & D'AGATI, V. D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2001-06
- Volume
- 12
- Issue
- 6
- Pages
- 1164-1172
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2131217979
- Cited by
- 466
- References
- 28
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.